• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑水肿中的加压素和加压素受体。

Vasopressin and vasopressin receptors in brain edema.

机构信息

Swedish Medical Center, Englewood, CO, United States.

Swedish Medical Center, Englewood, CO, United States.

出版信息

Vitam Horm. 2020;113:291-312. doi: 10.1016/bs.vh.2019.08.015. Epub 2019 Sep 13.

DOI:10.1016/bs.vh.2019.08.015
PMID:32138953
Abstract

Vasopressin is a peptide hormone produced in the hypothalamus and released from the posterior pituitary. Secretion of vasopressin is followed by activation of its receptors V1a, V1b, and V2 throughout the body. Each receptor type is responsible for a specific function of vasopressin. For example, V1a receptor activation triggers vasoconstriction, V1b receptor is responsible for modulation of mood and behavior, and V2 receptor induces water reabsorption in the kidney. Vasopressin is known to regulate blood pressure, blood osmolality, and blood volume. The effects of V1a and V2 receptors can be amplified when vasopressin is secreted in excessive amounts, and this condition may be experienced by patients undergoing a disease or stress. In pathological conditions such as stroke, traumatic brain injury, subarachnoid hemorrhage, liver disease, and other diseases, vasopressin can exacerbate brain edema. Oversecretion of vasopressin unleashes deleterious pathways leading to hyponatremia and brain edema. This book chapter describes important mechanisms and pathways linking vasopressin and brain edema triggered by various conditions.

摘要

血管升压素是一种由下丘脑产生并从垂体后叶释放的肽类激素。血管升压素的分泌会激活全身的 V1a、V1b 和 V2 受体。每种受体类型都负责血管升压素的特定功能。例如,V1a 受体的激活会引发血管收缩,V1b 受体负责调节情绪和行为,而 V2 受体则会诱导肾脏对水的重吸收。血管升压素已知可调节血压、血液渗透压和血容量。当血管升压素分泌过多时,V1a 和 V2 受体的作用会被放大,这种情况可能发生在患有疾病或压力的患者中。在中风、创伤性脑损伤、蛛网膜下腔出血、肝病和其他疾病等病理条件下,血管升压素会加重脑水肿。血管升压素的过度分泌会引发导致低钠血症和脑水肿的有害途径。本章描述了由各种条件引发的与血管升压素和脑水肿相关的重要机制和途径。

相似文献

1
Vasopressin and vasopressin receptors in brain edema.脑水肿中的加压素和加压素受体。
Vitam Horm. 2020;113:291-312. doi: 10.1016/bs.vh.2019.08.015. Epub 2019 Sep 13.
2
Vasopressin V1a and V1b receptors: from molecules to physiological systems.血管加压素 V1a 和 V1b 受体:从分子到生理系统。
Physiol Rev. 2012 Oct;92(4):1813-64. doi: 10.1152/physrev.00035.2011.
3
Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.小分子血管加压素V1a和V2受体拮抗剂对小鼠创伤性脑损伤后脑水肿形成及继发性脑损伤的影响。
J Neurotrauma. 2015 Feb 15;32(4):221-7. doi: 10.1089/neu.2013.3274. Epub 2014 Dec 16.
4
Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.精氨酸加压素受体阻滞剂考尼伐坦可减轻小鼠实验性中风后的脑水肿并减少血脑屏障破坏。
PLoS One. 2015 Aug 14;10(8):e0136121. doi: 10.1371/journal.pone.0136121. eCollection 2015.
5
Increased expression of vasopressin v1a receptors after traumatic brain injury.创伤性脑损伤后血管加压素V1a受体表达增加。
J Neurotrauma. 2004 Aug;21(8):1090-102. doi: 10.1089/0897715041651033.
6
Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.非肽类血管加压素受体拮抗剂:选择性及口服活性V1a、V2和V1b受体配体的研发
Prog Brain Res. 2002;139:197-210. doi: 10.1016/s0079-6123(02)39017-4.
7
Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.血管加压素通过V1b受体刺激胰岛细胞释放胰岛素:药理学与基因敲除相结合的研究方法
Mol Pharmacol. 2004 Mar;65(3):623-9. doi: 10.1124/mol.65.3.623.
8
Vasopressin and oxytocin in normal reproduction and in the pathophysiology of preterm labour and primary dysmenorrhoea. Development of receptor antagonists for therapeutic use in these conditions.血管加压素和催产素在正常生殖以及早产和原发性痛经病理生理学中的作用。用于这些病症治疗的受体拮抗剂的研发。
Rocz Akad Med Bialymst. 2004;49:18-21.
9
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.强效非肽类人血管加压素V1A和V2受体拮抗剂YM087的药理学特性
Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):63-9. doi: 10.1007/pl00005139.
10
Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.负责血管加压素与人神经垂体激素受体结合的相互作用分析——活化受体-血管加压素-G(α)系统的分子动力学研究
J Pept Sci. 2006 Mar;12(3):180-9. doi: 10.1002/psc.714.

引用本文的文献

1
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations.支持成人和儿科人群剂量选择的巴洛沙肽群体药代动力学模型。
J Pharmacokinet Pharmacodyn. 2024 Jun;51(3):227-242. doi: 10.1007/s10928-023-09898-0. Epub 2024 Feb 3.
2
Inhibition of insulin-regulated aminopeptidase confers neuroprotection in a conscious model of ischemic stroke.抑制胰岛素调节氨肽酶可在缺血性脑卒中的清醒模型中提供神经保护作用。
Sci Rep. 2023 Nov 13;13(1):19722. doi: 10.1038/s41598-023-46072-5.
3
Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides.
血管升压素及其类似物:从天然激素到多功能肽。
Int J Mol Sci. 2022 Mar 12;23(6):3068. doi: 10.3390/ijms23063068.
4
The Evolution of Oxytocin and Vasotocin Receptor Genes in Jawed Vertebrates: A Clear Case for Gene Duplications Through Ancestral Whole-Genome Duplications.有颌脊椎动物中催产素和加压素受体基因的进化:通过祖先全基因组复制产生基因加倍的明确案例。
Front Endocrinol (Lausanne). 2022 Feb 3;12:792644. doi: 10.3389/fendo.2021.792644. eCollection 2021.